2,719 Shares in Metsera Inc. $MTSR Bought by Virtus Investment Advisers LLC

Virtus Investment Advisers LLC acquired a new position in Metsera Inc. (NASDAQ:MTSR) in the second quarter, HoldingsChannel reports. The institutional investor acquired 2,719 shares of the company’s stock, valued at approximately $77,000.

Other large investors also recently added to or reduced their stakes in the company. Strs Ohio purchased a new position in shares of Metsera during the first quarter valued at about $76,000. KLP Kapitalforvaltning AS purchased a new stake in Metsera during the second quarter valued at approximately $122,000. Police & Firemen s Retirement System of New Jersey lifted its stake in shares of Metsera by 32.6% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 4,293 shares of the company’s stock valued at $122,000 after purchasing an additional 1,056 shares during the last quarter. Corebridge Financial Inc. purchased a new position in shares of Metsera in the 1st quarter worth approximately $206,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Metsera during the 1st quarter valued at approximately $248,000.

Analyst Ratings Changes

MTSR has been the subject of several recent analyst reports. Leerink Partners reaffirmed a “market perform” rating and set a $57.00 price objective (down from $77.00) on shares of Metsera in a research note on Wednesday, September 24th. Weiss Ratings restated a “sell (d)” rating on shares of Metsera in a research report on Wednesday, October 8th. Leerink Partnrs downgraded Metsera from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 24th. Cantor Fitzgerald restated an “overweight” rating on shares of Metsera in a report on Wednesday, September 3rd. Finally, Wall Street Zen raised Metsera from a “sell” rating to a “hold” rating in a research report on Wednesday, October 1st. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $55.75.

Metsera Price Performance

MTSR stock opened at $70.50 on Monday. Metsera Inc. has a 1-year low of $12.30 and a 1-year high of $83.86. The business has a 50-day moving average price of $60.55 and a 200 day moving average price of $42.49. The company has a market capitalization of $7.42 billion and a P/E ratio of -11.16.

Metsera (NASDAQ:MTSR) last announced its quarterly earnings results on Wednesday, November 12th. The company reported ($1.11) earnings per share for the quarter, missing the consensus estimate of ($0.56) by ($0.55).

Metsera Company Profile

Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.